It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Excerpted from: www.cbsnews.com...
On January 30th, President Trump used part of his State of the Union address to press Congress to focus attention in 2018 on a new health priority -- the passage of "right to try" legislation. It passed, and the president signed it today.
Right to try legislation gives terminally ill patients the right to use experimental medications that have not yet been approved by the Food and Drug Administration.
President Trump's push for the passage of right to try nationally builds on the efforts of the libertarian-leaning Goldwater Institute, which has used the broad popularity of the policy to help achieve passage of similar legislation in 38 states, although the state legislation differs substantially from the version signed by the President today.
Just one example of how your source contradicts your opinion. Did you read it?
IMO, this RIGHT TO TRY legislation will open the door to easier FDA approval of some medications, save lives, and other benefits that we haven't thought of yet.
Providing the drug to patients outside of clinical trials can also be disruptive to the approval process because it can lead to data on negative clinical outcomes outside the highly controlled trial setting. While new legislation prevents this data from being used unless it is deemed "critical to determining safety," bad outcomes might give the FDA pause and delay the approval of drugs that might otherwise be available sooner.
Beyond these issues, federal right to try legislation will have minimal impact on the availability of experimental drugs for patients. Not only have 38 states already passed similar legislation, but the FDA already has a program in place designed to provide patients with experimental medications.
The right to try legislation will score the president and members on both sides of the aisle in Congress points, but ultimately it will change little for terminally ill patients and their families.
originally posted by: FyreByrd
a reply to: carewemust
Does that mean that insurance will pay for it? Don't think so. Sounds good on paper - rich people won't be breaking the law - but not much good in practice for the constituency.
Oh, I forgot for a minute - Rich people are the only constituency.
You're correct. There are pros and cons to everything. If you're terminally ill, having the RIGHT TO TRY is a good thing, from your perspective.
originally posted by: Phage
a reply to: carewemust
Just one example of how your source contradicts your opinion. Did you read it?
IMO, this RIGHT TO TRY legislation will open the door to easier FDA approval of some medications, save lives, and other benefits that we haven't thought of yet.
Providing the drug to patients outside of clinical trials can also be disruptive to the approval process because it can lead to data on negative clinical outcomes outside the highly controlled trial setting. While new legislation prevents this data from being used unless it is deemed "critical to determining safety," bad outcomes might give the FDA pause and delay the approval of drugs that might otherwise be available sooner.
Beyond these issues, federal right to try legislation will have minimal impact on the availability of experimental drugs for patients. Not only have 38 states already passed similar legislation, but the FDA already has a program in place designed to provide patients with experimental medications.
The right to try legislation will score the president and members on both sides of the aisle in Congress points, but ultimately it will change little for terminally ill patients and their families.
That's an interesting point, but the law seems to be silent on parents allowing such treatment for terminally ill children. It seems to apply only to the patient, presumably an adult patient. So the lawyers still have jobs.
If this law does nothing else, it will insure that we don't have armed police standing outside of a hospital keeping parents from taking their child elsewhere for treatment.
“(a) Definitions.—For purposes of this section—
“(1) the term ‘eligible patient’ means a patient—
“(A) who has been diagnosed with a life-threatening disease or condition (as defined in section 312.81 of title 21, Code of Federal Regulations (or any successor regulations));
“(B) who has exhausted approved treatment options and is unable to participate in a clinical trial involving the eligible investigational drug, as certified by a physician, who—
“(i) is in good standing with the physician’s licensing organization or board; and
“(ii) will not be compensated directly by the manufacturer for so certifying; and
“(C) who has provided to the treating physician written informed consent regarding the eligible investigational drug, or, as applicable, on whose behalf a legally authorized representative of the patient has provided such consent;
I would think the FDA and the AMA would do everything they can to block this !!
But, it's unfortunate that on the flip side, parents can legally withhold proven treatments for their children who could otherwise live. Things like blood transfusions. Devil's work.
But the science part of medicine recognizes that, lacking controls, any results gained (or lost) will not add to the knowledge base. Each case (whatever the outcome) will be anecdotal. If the patient survives, for ever how long, there is no statistical basis to support the treatment. If the patient suffers terrible side effects, there is nothing to hinder the next patient from suffering the same.
Now I think about it, it's looking more obvious that the field of medicine would be open to trialling experimental, novel treatments with the consent of terminally ill patients.